Datt Mediproducts Ltd
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE 8.04 %
- ROE 7.05 %
- Face Value ₹ 10.0
Pros
Cons
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | |
|---|---|---|
| 61.11 | 69.72 | |
| 56.87 | 64.28 | |
| Operating Profit | 4.24 | 5.44 |
| OPM % | 6.94% | 7.80% |
| 0.89 | -0.02 | |
| Interest | 1.37 | 1.41 |
| Depreciation | 1.99 | 1.94 |
| Profit before tax | 1.77 | 2.07 |
| Tax % | 23.16% | 38.65% |
| 1.36 | 1.27 | |
| EPS in Rs | ||
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | |
|---|---|---|
| Equity Capital | 13.22 | 13.22 |
| Reserves | 4.87 | 6.14 |
| 24.41 | 26.82 | |
| 9.81 | 12.00 | |
| Total Liabilities | 52.31 | 58.18 |
| 20.52 | 20.42 | |
| CWIP | 0.09 | 0.11 |
| Investments | 0.65 | 1.71 |
| 31.05 | 35.94 | |
| Total Assets | 52.31 | 58.18 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | |
|---|---|---|
| 1.67 | 3.19 | |
| -2.15 | -3.44 | |
| 1.02 | 1.21 | |
| Net Cash Flow | 0.54 | 0.96 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | |
|---|---|---|
| Debtor Days | 51.19 | 54.87 |
| Inventory Days | 214.89 | 236.61 |
| Days Payable | 50.26 | 60.68 |
| Cash Conversion Cycle | 215.82 | 230.79 |
| Working Capital Days | 122.80 | 120.25 |
| ROCE % | 8.04% |
Documents
Announcements
No data available.
Annual reports
No data available.